Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Lascaux

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Presse Medicale (Paris, France : 1983)|June 30, 2000
[Current therapeutics in infectious dermatology]A S Lascaux, O Chosidow
Annales De Dermatologie Et De Venereologie|May 4, 2002
[Profuse scabies: kinetic curves of parasitologic cure with an association of benzyl benzoate and sulfiram]P Pitche, P Wolkenstein, G Cremer, et al.
Annales De Dermatologie Et De Venereologie|September 25, 1998
[Cutaneous manifestations during disseminated trichosporonosis in an AIDS patient]A S Lascaux, F Bouscarat, V Descamps, et al.
Annales De Dermatologie Et De Venereologie|May 18, 2010
[Erythema elevatum diutinum associated with pyoderma gangrenosum in an HIV-positive patient]L Maksimovic, P Duriez, A-S Lascaux-Cametz, et al.
AIDS Research and Human Retroviruses|March 30, 2005
Beneficial effect of highly active antiretroviral therapy on the prognosis of AIDS-related systemic non-Hodgkin lymphomasA S Lascaux, F Hemery, C Goujard, et al.
HIV Clinical Trials|October 9, 2001
Lipodystrophy in 685 HIV-1-treated patients: influence of antiretroviral treatment and immunovirological responseF Boufassa, A Dulioust, A S Lascaux, et al.
The Journal of Antimicrobial Chemotherapy|June 4, 2011
Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavirT Bommenel, O Launay, J L Meynard, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Presse Medicale (Paris, France : 1983)|June 30, 2000
[Current therapeutics in infectious dermatology]A S Lascaux, O Chosidow
Annales De Dermatologie Et De Venereologie|May 4, 2002
[Profuse scabies: kinetic curves of parasitologic cure with an association of benzyl benzoate and sulfiram]P Pitche, P Wolkenstein, G Cremer, et al.
Annales De Dermatologie Et De Venereologie|September 25, 1998
[Cutaneous manifestations during disseminated trichosporonosis in an AIDS patient]A S Lascaux, F Bouscarat, V Descamps, et al.
Annales De Dermatologie Et De Venereologie|May 18, 2010
[Erythema elevatum diutinum associated with pyoderma gangrenosum in an HIV-positive patient]L Maksimovic, P Duriez, A-S Lascaux-Cametz, et al.
AIDS Research and Human Retroviruses|March 30, 2005
Beneficial effect of highly active antiretroviral therapy on the prognosis of AIDS-related systemic non-Hodgkin lymphomasA S Lascaux, F Hemery, C Goujard, et al.
HIV Clinical Trials|October 9, 2001
Lipodystrophy in 685 HIV-1-treated patients: influence of antiretroviral treatment and immunovirological responseF Boufassa, A Dulioust, A S Lascaux, et al.
The Journal of Antimicrobial Chemotherapy|June 4, 2011
Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavirT Bommenel, O Launay, J L Meynard, et al.
Pageof 1